SauratJH. Eczema in primary immune-deficiencies: Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol1985; 114:125–128.
2.
LeungDYMWoodNDubeyD. Cellular basis of defective cell-mediated lympholysis in atopic dermatitis. J Immunol1983; 130:1678–1682.
3.
OhmanJDHanifinJMNickoloffBJ. Overexpression of IL-10 in atopic dermatitis: Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol1995; 154:1956–1963.
4.
ReinholdUPawelecGWehrmannW. Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol1988; 87:120–126.
5.
RystedtIStrannegardILStrannegardO. Recurrent viral infections in patients with past or present atopic dermatitis. Br J Dermatol1986; 114:575–582.
6.
RystedtIStrannegardILStrannegardO. Infections as contributing factors to atopic dermatitis. Eur J Allergy Clin Immunol1989; 44 (Suppl 9):79–83.
CurrieJMWrightRCMillerOW. The frequency of warts in atopic patients. Cutis1971; 8:244–245.
9.
StrannegardOStrannegardILRystedtI. Viral infections in atopic dermatitis. Acta Derm Venereol1985; 114(Suppl):121–124.
10.
GoodyearHMDaviesJAMcLeishP. Growth of herpes simplex type 1 on skin explants of atopic eczema. Clin Exp Dermatol1996; 21:185–189.
11.
RaychaudhuriSPRaychaudhuriSK. Revisit to Kaposi's varicelliform eruption: Role of IL-4. Int J Dermatol1995; 34:854–856.
12.
GoodyearHMMcLeishPRandallS. Immunological studies of herpes simplex virus infection in children with atopic eczema. Br J Dermatol1996; 134:85–93.
13.
FujimuraTYamanashiRMasuzawaM. Conversion of the CD4+ T cell profile from T(h2)-dominant type to T(h1)-dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol1997; 100:274–282.
14.
ChretienIPeneJBriereF. Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma. Eur J Immunol1990; 20:243–251.
15.
OswaldIPCasparPJankovicD. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni.J Immunol1994; 153:1707–1713.
16.
BorkKBrauningerW. Increasing incidence of eczema herpeticum: Analysis of seventy-five cases. J Am Acad Dermatol1988; 19:1024–1029.
17.
JonesHEReinhardtJHRinaldiMG. A clinical, mycolodical, and immunological survey for dermatophytosis. Arch Dermatol1973; 108:61–65.
18.
SvejgaardEFaergemanJJemecG. Recent investigations on the relationship between fungal skin diseases and atopic dermatitis. Acta Derm Venereol1989; 144(Suppl):140–142.
19.
JonesHE. The atopic-chronic-dermatophytosis syndrome. Acta Derm Venereol (Stockh)1980; 92(Suppl):81–85.
20.
WilsonBBDeuellBMillsTA. Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis1993; 51:191–192.
BrobergA. Pityrosporum ovale in healthy children, infantile seborrhoeic dermatitis and atopic dermatitis. Acta Derm Venereol1995; 191(Suppl):1–47.
23.
HenselerTTauschI. [Mycoses in patients with psoriasis or atopic dermatitis. German] Mycoses1997; 40(Suppl 1):22–28.
24.
KolmerHLTaketomiEAHazenKC. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis. J Allergy Clin Immunol1996; 98:702–707.
25.
BrobergAFaergemannJ. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomized study. Acta Derm Venereol1995; 75:46–49.
26.
BrookIFrazierEHYeagerJK. Microbiology of infected atopic dermatitis. Int J Dermatol1996; 35:791–793.
27.
McFaddenJPNobleWCCampRDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol1993; 128:631–632.
28.
MollickJAMcMastersRLGrossmanD. Localization of a site on bacterial superantigens that determines T cell receptor β chain specificity. J Exp Med1993; 177:283–293.
29.
LeungDYMGatelyMTrumbleA. Bacterial superantigens induce T cell expression of the skin—selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med1995; 181:747–753.
30.
LeungDYMCotranRSPoberJS. Expression of an endothelial leukocyte adhesion molecule (ELAM-1) in elicited late phase allergic skin reactions. J Clin Invest1991; 87:1805–1810.
31.
LeungDYMHarbeckRBinaP. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens. J Clin Invest1993; 92:1374–1380.
32.
NissenDPedersenLJSkovPS. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol1997; 79:403–408.
33.
TadaJToiYAkiyamaH. Presence of specific IgE antibodies to staphylococcal enterotoxins in patients with atopic dermatitis. Eur J Dermatol1996; 6:552–554.
34.
GohCLWongJSGiamYC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol1997; 36:653–657.
35.
LeydenJEMarplesRRKligmanAM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol1974;90:525–530.
36.
ColeGWSilverbergNL. The adherence of Staphylococcus aureus to human corneocytes. Arch Dermatol1986; 122:166–169.
37.
StalderJFFleuryMSourisseM. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol1994; 131:536–540.
38.
LeverRKHadleyDDowneyMackieR. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol1988; 119:189–198.
39.
SugimotoKKurokiHKanazawaM. New successful treatment with disinfectant for atopic dermatitis. Dermatology1997; 195(Suppl 2):62–68.
